190 related articles for article (PubMed ID: 35165799)
1. 1-(7-Chloroquinolin-4-yl)-N-(4-Methoxybenzyl)-5-Methyl-1H-1,2, 3-Triazole-4- carboxamide Reduces Aβ Formation and Tau Phosphorylation in Cellular Models of Alzheimer's Disease.
Fronza MG; Sacramento M; Alves D; Praticò D; Savegnago L
Neurochem Res; 2022 Apr; 47(4):1110-1122. PubMed ID: 35165799
[TBL] [Abstract][Full Text] [Related]
2. QTC-4-MeOBnE Ameliorated Depressive-Like Behavior and Memory Impairment in 3xTg Mice.
Fronza MG; Sacramento M; Alves D; Praticò D; Savegnago L
Mol Neurobiol; 2023 Mar; 60(3):1733-1745. PubMed ID: 36567360
[TBL] [Abstract][Full Text] [Related]
3. Rational design, cognition and neuropathology evaluation of QTC-4-MeOBnE in a streptozotocin-induced mouse model of sporadic Alzheimer's disease.
Fronza MG; Baldinotti R; Martins MC; Goldani B; Dalberto BT; Kremer FS; Begnini K; Pinto LDS; Lenardão EJ; Seixas FK; Collares T; Alves D; Savegnago L
Sci Rep; 2019 May; 9(1):7276. PubMed ID: 31086208
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of QTC-4-MeOBnE in an LPS-induced mouse model of depression and cognitive impairments: The role of blood-brain barrier permeability, NF-κB signaling, and microglial activation.
Fronza MG; Baldinotti R; Fetter J; Rosa SG; Sacramento M; Nogueira CW; Alves D; Praticò D; Savegnago L
Brain Behav Immun; 2022 Jan; 99():177-191. PubMed ID: 34624485
[TBL] [Abstract][Full Text] [Related]
5. QTC-4-MeOBnE Rescues Scopolamine-Induced Memory Deficits in Mice by Targeting Oxidative Stress, Neuronal Plasticity, and Apoptosis.
Fronza MG; Baldinotti R; Fetter J; Sacramento M; Sousa FSS; Seixas FK; Collares T; Alves D; Praticò D; Savegnago L
ACS Chem Neurosci; 2020 May; 11(9):1259-1269. PubMed ID: 32227985
[TBL] [Abstract][Full Text] [Related]
6. Toluidine blue O attenuates tau phosphorylation in N2a-APPSwe cells.
Onder S; Biberoglu K; Yuksel M; Tacal O
Chem Biol Interact; 2022 Oct; 366():110126. PubMed ID: 36027949
[TBL] [Abstract][Full Text] [Related]
7. Effect of QTC-4-MeOBnE Treatment on Memory, Neurodegeneration, and Neurogenesis in a Streptozotocin-Induced Mouse Model of Alzheimer's Disease.
Fronza MG; Baldinotti R; Sacramento M; Gutierres J; Carvalho FB; Fernandes MDC; Sousa FSS; Seixas FK; Collares T; Alves D; Pratico D; Savegnago L
ACS Chem Neurosci; 2021 Jan; 12(1):109-122. PubMed ID: 33315382
[TBL] [Abstract][Full Text] [Related]
8. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.
Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D
PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757
[TBL] [Abstract][Full Text] [Related]
9. Cypermethrin Stimulates GSK3β-Dependent Aβ and p-tau Proteins and Cognitive Loss in Young Rats: Reduced HB-EGF Signaling and Downstream Neuroinflammation as Critical Regulators.
Maurya SK; Mishra J; Abbas S; Bandyopadhyay S
Mol Neurobiol; 2016 Mar; 53(2):968-982. PubMed ID: 25575682
[TBL] [Abstract][Full Text] [Related]
10. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
eNeuro; 2017; 4(2):. PubMed ID: 28374012
[TBL] [Abstract][Full Text] [Related]
11. Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity.
Jantrapirom S; Nimlamool W; Chattipakorn N; Chattipakorn S; Temviriyanukul P; Inthachat W; Govitrapong P; Potikanond S
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138327
[TBL] [Abstract][Full Text] [Related]
12. Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease.
Peng Y; Hu Y; Xu S; Rong X; Li J; Li P; Wang L; Yang J; Wang X
J Pharmacol Exp Ther; 2014 Aug; 350(2):361-74. PubMed ID: 24893984
[TBL] [Abstract][Full Text] [Related]
13. Key Peptides and Proteins in Alzheimer's Disease.
Penke B; Bogár F; Paragi G; Gera J; Fülöp L
Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase 5 inhibitor mirodenafil ameliorates Alzheimer-like pathology and symptoms by multimodal actions.
Kang BW; Kim F; Cho JY; Kim S; Rhee J; Choung JJ
Alzheimers Res Ther; 2022 Jul; 14(1):92. PubMed ID: 35804462
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
Chu J; Lauretti E; Craige CP; Praticò D
J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099
[TBL] [Abstract][Full Text] [Related]
16. NPD1 Enhances Autophagy and Reduces Hyperphosphorylated Tau and Amyloid-β42 by Inhibiting GSK3β Activation in N2a/APP695swe Cells.
Dai S; Zhou F; Sun J; Li Y
J Alzheimers Dis; 2021; 84(2):869-881. PubMed ID: 34602482
[TBL] [Abstract][Full Text] [Related]
17. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
Zhang ZX; Zhao RP; Wang DS; Wang AN
Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601
[TBL] [Abstract][Full Text] [Related]
18. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
[TBL] [Abstract][Full Text] [Related]
19. GRK5 influences the phosphorylation of tau via GSK3β and contributes to Alzheimer's disease.
Zhao J; Li X; Chen X; Cai Y; Wang Y; Sun W; Mai H; Yang J; Fan W; Tang P; Ou M; Zhang Y; Huang X; Zhao B; Cui L
J Cell Physiol; 2019 Jul; 234(7):10411-10420. PubMed ID: 30511419
[TBL] [Abstract][Full Text] [Related]
20. The neurobiology and therapeutic potential of multi-targeting β-secretase, glycogen synthase kinase 3β and acetylcholinesterase in Alzheimer's disease.
Fronza MG; Alves D; Praticò D; Savegnago L
Ageing Res Rev; 2023 Sep; 90():102033. PubMed ID: 37595640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
